Filing Flows

Filing Flows › SeaStar Medical Holding (ICU) › Q1 2026 › vs Q1 2025

SeaStar Medical Holding (ICU) Q1 2026 vs Q1 2025 (year over year)

SeaStar Medical Holding's revenue rose $202K (+69%) from $293K in Q1 2025 to $495K in Q1 2026.

SeaStar Medical Holding, Q1 2026: revenue $495K (+69% year over year), operating margin -727.9%, net loss $3.5M, operating cash flow −$2.8M. The chart draws each line against Q1 2025, the increases inside each band.

SeaStar Medical Holding: what changed, Q1 2026 vs Q1 2025SeaStar Medical Holding: what changed, Q1 2026 vs Q1 2025Working capital & other−$282KNet loss−$251KOperating cash sources−$251KNet loss absorbed−$251KCash used in operations$107KResearch & development−$87KShare-based compensation−$76KCost of revenue$46KOther income, net$32KGeneral & admin$24K

Every line

LineQ1 2026Q1 2025Change%
Revenue$495K$293K$202K+69%
Other income, net$85K$53K$32K+60%
Net loss$3.5M$3.8M−$251K-7%
Costs & expenses$4.1M$4.1M−$17K-0.4%
Operating costs$4.1M$4.1M−$17K-0.4%
Income tax$3K$3K$00%
Cost of revenue$46K$0$46K—
Research & development$2.3M$2.4M−$87K-4%
General & admin$1.7M$1.7M$24K+1%
Operating cash sources$3.5M$3.8M−$251K-7%
Share-based compensation$91K$167K−$76K-46%
Working capital & other$669K$951K−$282K-30%
Cash used in operations$2.8M$2.7M$107K+4%
Net loss absorbed$3.5M$3.8M−$251K-7%

Questions

How much did SeaStar Medical Holding's revenue grow year over year in Q1 2026?

SeaStar Medical Holding's revenue rose $202K (+69%) from $293K in Q1 2025 to $495K in Q1 2026.

Q1 2026 results → · Compare in the interactive Sankey →